197 related articles for article (PubMed ID: 9731514)
1. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW
Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
4. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
[TBL] [Abstract][Full Text] [Related]
5. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
Emenaker NJ; Basson MD
J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
[TBL] [Abstract][Full Text] [Related]
6. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.
Williams LM; Gibbons DL; Gearing A; Maini RN; Feldmann M; Brennan FM
J Clin Invest; 1996 Jun; 97(12):2833-41. PubMed ID: 8675695
[TBL] [Abstract][Full Text] [Related]
8. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
11. Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells.
Kadono Y; Shibahara K; Namiki M; Watanabe Y; Seiki M; Sato H
Biochem Biophys Res Commun; 1998 Oct; 251(3):681-7. PubMed ID: 9790969
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors.
Ahonen M; Poukkula M; Baker AH; Kashiwagi M; Nagase H; Eriksson JE; Kähäri VM
Oncogene; 2003 Apr; 22(14):2121-34. PubMed ID: 12687014
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate.
Farina AR; Tacconelli A; Teti A; Gulino A; Mackay AR
Cancer Res; 1998 Jul; 58(14):2957-60. PubMed ID: 9679953
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Collins HM; Morris TM; Watson SA
Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis.
Apparailly F; Noël D; Millet V; Baker AH; Lisignoli G; Jacquet C; Kaiser MJ; Sany J; Jorgensen C
Arthritis Rheum; 2001 Jun; 44(6):1444-54. PubMed ID: 11407707
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
Grossetete M; Rosenberg GA
J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
[TBL] [Abstract][Full Text] [Related]
18. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
Müllberg J; Durie FH; Otten-Evans C; Alderson MR; Rose-John S; Cosman D; Black RA; Mohler KM
J Immunol; 1995 Dec; 155(11):5198-205. PubMed ID: 7594530
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
Amano S; Ogura Y; Akutsu N; Matsunaga Y; Kadoya K; Adachi E; Nishiyama T
Br J Dermatol; 2005 Dec; 153 Suppl 2():37-46. PubMed ID: 16280020
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.
DeClerck YA; Yean TD; Chan D; Shimada H; Langley KE
Cancer Res; 1991 Apr; 51(8):2151-7. PubMed ID: 2009533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]